123
Views
3
CrossRef citations to date
0
Altmetric
Original Article

Risk factors for recurrence of borderline ovarian tumours: A tertiary centre experience

, , , , , , & show all
Pages 1036-1040 | Received 21 Jul 2015, Accepted 26 Apr 2016, Published online: 25 Aug 2016

References

  • Ayhan A, Guvendag Guven ES, Guven S, Kucukali T. 2005. Recurrence and prognostic factors in borderline ovarian tumors. Gynecologic Oncology 98:439–445.
  • Bell DA, Weinstock MA, Scully RE. 1988. Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis. Cancer 62:2212–2222.
  • Burger CW, Prinssen HM, Baak JP, Wagenaar N, Kenemans P. 2000. The management of borderline epithelial tumors of the ovary. International Journal of Gynecological Cancer 10:181–197.
  • Guvenal T, Dursun P, Hasdemir PS, Hanhan M, Guven S, Yetimalar H, et al. 2013. Effect of surgical staging on 539 patients with borderline ovarian tumors: a Turkish gynecologic oncology group study. Gynecologic Oncology 131:546–550.
  • Mink P, Sherman ME, Devesa S. 2002. Incidence patterns of invasive and borderline ovarian tumors among white women and black women in the United States. Results from the SEER Program, 1978-1998. Cancer 95:2380–2389.
  • Morice P, Camatte S, El Hassan J, Pautier P, Duvillard P, Castaigne D. 2001. Clinical outcomes and fertility after conservative treatment of ovarian borderline tumors. Fertility and Sterility 75:92–96.
  • NCCN. 2013. National Comprehensive Cancer Network. Clinical practice guidelines in oncology. Ovarian, fallopian tube and primary peritoneal cancers 1.
  • Prat J; for the FIGO Committee on Gynecologic Oncology 2014. Staging classification for cancer of the ovary, fallopian tube, and peritoneum. International Journal of Gynaecology and Obstetrics 124:1–5.
  • Ren J, Peng Z, Yang K. 2008. A clinicopathologic multivariate analysis affecting recurrence of borderline ovarian tumors. Gynecologic Oncology 110:162–167.
  • Seidman JD, Kurman RJ. 2000. Ovarian serous borderline tumors: a critical review on the literature with emphasis on prognostic factors. Human Pathology 31:529–557.
  • Shih KK, Zhou Q, Huh J, Morgan JC, Iasonos A, Aghajanian C, et al. 2011. Risk factors for recurrence of ovarian borderline tumors. Gynecologic Oncology 120:480–484.
  • Silva EG, Gershenson DM, Malpica A, Deavers M. 2006. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. The American Journal of Surgical Pathology 30:1367–1371.
  • Suh-Burgmann E. 2006. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study. Gynecologic Oncology 103:841–847.
  • Tavassoli FA, Devilee P. 2003. World Health Organization classification of tumours. Pathology and genetics of tumours of the breast and female genital organs. Lyon (France): IARC.
  • Tinelli R, Malzoni M, Cosentino F, Perone C, Tinelli A, Malvasi A, et al. 2009. Feasibility, safety, and efficacy of conservative laparoscopic treatment of borderline ovarian tumors. Fertility and Sterility 92:736–741.
  • Trimble CL, Kosary C, Trimble EL. 2002. Long-term survival and patterns of care in women with ovarian tumors of low malignant potential. Gynecologic Oncology 86:34–37.
  • Van Calster B, Timmerman D, Bourne T, Testa AC, Van Holsbeke C, Domali E, et al. 2007. Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125. Journal of the National Cancer Institute 99:1706–1714.
  • Wu TI, Lee CL, Wu MY, Hsueh S, Huang KG, Yeh CJ, et al. 2009. Prognostic factors predicting recurrence in borderline ovarian tumors. Gynecologic Oncology 114:237–241.
  • Zanetta G, Rota S, Chiari S, Bonazzi C, Bratina G, Mangioni C. 2001. Behavior of borderline tumors with particular interest to persistence, recurrence and progression to invasive carcinoma: a prospective study. Journal of Clinical Oncology 19:2658–2664.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.